Tissue distribution of the guinea-pig decay-accelerating factor

Immunology

Volumn 95, Issue 2, 1998, Pages 302-307

  Nishikawa, K ^a   Matsuo, S ^a   Tamai, H ^b   Okada, N ^c   Okada, H ^c  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ANJO KOSEI HOSPITAL   (Japan)

^c NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DECAY ACCELERATING FACTOR; MONOCLONAL ANTIBODY;

ANIMAL CELL; ARTICLE; EPIDERMIS CELL; FEMALE; GUINEA PIG; IMMUNOFLUORESCENCE TEST; KIDNEY TUBULE EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SKIN; SYNOVIOCYTE; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIGENS, CD55; BRAIN; CAPILLARIES; ENDOTHELIUM, VASCULAR; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GUINEA PIGS; KIDNEY; LIVER; MYOCARDIUM; OVARY; SKIN; SYNOVIAL MEMBRANE; THYMUS GLAND; TISSUE DISTRIBUTION; URINARY BLADDER; UTERUS;

EID: 0031721719     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1998.00592.x     Document Type: Article

References (35)

1. HOFFMAN E.M. (1969) Inhibition of complement by a substance isolated from human erythrocytes. II. Studies on the site and mechanism of action. Immunochemistry 6, 405.
2. NICHOLSON-WELLER A., BURGE J., FEARON D.T., WELLER P.F. & AUSTEN K.F. (1982) Isolation of a human crythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J Immunol 129, 184.
3. MEDOF M.E., KINOSHITA T. & NUSSENZWEIG V. (1984) Inhibition of complement activation on the surface of cells after incorporation of decay accelerating factor (DAF) into their membranes. J Exp Med 160, 1558.
4. COLE J.L., HOUSLEY G.A. JR., DYKMAN T.R., MACDERMOTT R.P. & ATKINSON J.P. (1985) Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines. Proc Natl Acad Sci USA 82, 859.
5. ZALMAN L.S., WOOD L.M. & MÜLLER-EBERHARD H.J. (1986) Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels. Proc Natl Acad Sci USA 83, 6975.
6. SCHÖNERMARK S., RAUTERBERG E.W., SHIN M.L., LÖKE S., ROELCKE D. & HÄNSCH G.M. (1986) Homologous species restriction in lysis of human erthyrocytes: a membrane-derived protein with C8-binding capacity functions as an inhibitor. J Immunol 136, 1772.
7. OKADA N., HARADA R., FUJITA T. & OKADA H. (1989) A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement. Int Immunol 1, 205.
8. HOLGUIN M.H., FREDRICK L.R., BERNSHAW N.J., WILCOX L.A. & PARKER C.J. (1989) Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria. J Clin Invest 84, 7.
9. DAVIES A., SIMMONS D.L., HALE G., HARRISON R.A., TIGHE H., LACHMANN P.J. & WALDMANN H. (1989) CD59, an Ly-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J Exp Med 170, 637.
10. OKADA N., HARADA R., FUJITA T. & OKADA H. (1989) Monoclonal antibodies capable of causing hemolysis of neuramidase-treated human erythrocytes by homologous complement. J Immunol 143, 2262.
11. HARADA R., OKADA N., FUJITA T. & OKADA H. (1990) Purification of IF5 antigen that prevents complement attach on homologous cell membranes. J Immunol 144, 1823.
12. TAKIZAWA H., OKADA N. & OKADA H. (1994) Complement inhibitor of rat cell membrane resembling mouse Crry/P65. J Immunol 152, 3032.
13. SAKURADA C., SENO H., DOHI N., TAKIZAWA H., NONAKA M., OKADA N. & OKADA H. (1994) Molecular cloning of the rat complement regulatory protein, 512 antigen. Biochem Biophys Res Commun 198, 819.
14. OKADA N., TANAKA H., TAKIZAWA H. & OKADA H. (1995) A monoclonal antibody which blocks the complement regulatory activity of guinea pig erythrocytes and characterization as guinea pig decay accelerating factor. J Immunol 154, 6103.
15. NISHIKAGE H., BARANYI L., OKADA H. et al. (1995) The role of a complement regulatory protein in rat mesangial glomerulonephritis. J Am Soc Nephrol 6, 234.
16. HATANAKA Y., YUZAWA Y., NISHIKAWA K. et al. (1995) Role of a rat membrane inhibitor of complement in anti-basement membrane antibody-induced renal injury. Kidney Int 48, 1728.
17. MATSUO S., ICHIDA S., TAKIZAWA H. et al. (1994) In vivo effects of monoclonal antibodies that functionally inhibit complement regulatory proteins in rats. J Exp Med 180, 1619.
18. NOMURA A., NISHIKAWA K., YUZAWA Y. et al. (1995) Tubulointerstitial injury induced in rats by a monoclonal antibody that inhibits function of a membrane inhibitor of complement. J Clin Invest 96, 2348.
19. NISHIKAWA K., MATSUO S., OKADA N., MORGAN B.P. & OKADA H. (1996) Local inflammation caused by a monoclonal antibody that blocks the function of the rat membrane inhibitor of C3 convertase. J Immunol 156, 1182.
20. NONAKA M., MIWA T., OKADA N., NONAKA M. & OKADA H. (1995) Multiple isoforms of guinea pig decay-accelerating factor (DAF) generated by alternative splicing. J Immunol 155, 3037.
21. TANAKA H., IKEGAYA M. & OKADA H. (1981) Preparation of monoclonal antibodies which sensitize guinea pig erythrocytes for hemolysis by homologous complement. Proc Comp Symp 18, 13 (in Japanese).
22. MEDOF M.E., WALTER E.I., RUTGERS J.L., KNOWLES D.M. & NUSSENZWEIG V. (1987) Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids. J Exp Med 165, 848.
23. LUBLIN D.M. & ATKINSON J.P. (1989) Decay-accelerating factor: biochemistry, molecular biology and function. Ann Rev Immunol 7, 35.
24. ICHIDA S., YUZAWA Y., OKADA H., YOSHIOKA K. & MATSUO S. (1994) Localization of the complement regulatory proteins in the normal human kidney. Kidney Int 46, 89.
25. NATH K.A., HOSTETTER M.K. & HOSTETTER T.H. (1985) Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3. J Clin Invest 76, 667.
26. HOSTETTER M.K. (1993) The third component of complement: new functions for an old friend. J Lab Clin Med 122, 491.
27. ABBINK J.J., KAMP A.M., NUIJIENS J.H., EERENBERG A.J.M., SWAAK A.J.G. & HACK C.E. (1992) Relative contribution of contact and complement activation to inflammatory reactions in arthritic joints. Ann Rheum Dis 51, 1123.
28. RUDDY S. & COLTEN H.R. (1992) Biosynthesis of complement component proteins by synovial tissues. N Engl J Med 290, 1284.
29. WHALEY K., GUC D., GULATI P. & LAPPIN D. (1992) Synthesis of complement components by synovial membrane. Immunopharmacology 24, 83.
30. KAMEYOSHI Y., MATSUSHITA M. & OKADA H. (1989) Murine membrane inhibitor of complement which accelerates decay of human C3 convertase. Immunology 68, 439.
31. SPICER A.P., SELDIN M.F. & GENDLER S.J. (1995) Molecular cloning and chromosomal localization of the mouse decay-accelerating factor genes: duplicated genes encode glycosylphosphatidylinositol-anchored and transmembrane forms. J Immunol 155, 3079.
32. MOLINA H., WONG W., KINOSHITA T., BRENNER C., FOLEY S. & HOLERS V.M. (1992) Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1. J Exp Med 175, 121.
33. KIM Y.U., KINOSHITA T., MOLINA H. et al. (1995) Mouse complement regulatory protein crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. J Exp Med 181, 151.
34. FUNABASHI K., OKADA N., MATSUO S., YAMAMOTO T., MORGAN B.P. & OKADA H. (1994) Tissue distribution of complement regulatory membrane protein in rats. Immunology 81, 444.
35. WANG G., NONAKA M., HE C., OKADA N., NAKASHIMA I. & OKADA H. (1998) Functional differences among multiple isoforms of guinea pig decay accelerating factor (DAF). J Immunol 160, 3014.